279 related articles for article (PubMed ID: 16806271)
1. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
Leroi I; Collins D; Marsh L
J Neurol Sci; 2006 Oct; 248(1-2):104-14. PubMed ID: 16806271
[TBL] [Abstract][Full Text] [Related]
2. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
Vale S
Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
[TBL] [Abstract][Full Text] [Related]
3. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
Maidment ID; Fox C; Boustani M
Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Chen JJ; Swope DM; Dashtipour K
Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and behavioural impairment in Parkinson's disease.
Merims D; Freedman M
Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and dementia in Parkinson's disease.
Marder K
Mov Disord; 2010; 25 Suppl 1():S110-6. PubMed ID: 20187235
[TBL] [Abstract][Full Text] [Related]
7. Treatment of early Parkinson's disease. Part 2.
Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
[TBL] [Abstract][Full Text] [Related]
8. Treatments for Parkinson disease--past achievements and current clinical needs.
Poewe W
Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
[TBL] [Abstract][Full Text] [Related]
9. Psychosis in nursing home patients with Parkinson's disease.
Kang GA; Bronstein JM
J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
Goetz CG; Emre M; Dubois B
Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
[TBL] [Abstract][Full Text] [Related]
11. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Miyasaki JM; Shannon K; Voon V; Ravina B; Kleiner-Fisman G; Anderson K; Shulman LM; Gronseth G; Weiner WJ;
Neurology; 2006 Apr; 66(7):996-1002. PubMed ID: 16606910
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
Coelho M; Ferreira J; Rosa M; Sampaio C
Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
[TBL] [Abstract][Full Text] [Related]
13. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
Guay DR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine in Parkinson's disease dementia.
Chitnis S; Rao J
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment in Parkinson's disease.
Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
[TBL] [Abstract][Full Text] [Related]
16. Management for motor and non-motor complications in late Parkinson's disease.
Chan DK; Cordato DJ; O'Rourke F
Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
[TBL] [Abstract][Full Text] [Related]
19. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
Emre M; Ford PJ; Bilgiç B; Uç EY
Mov Disord; 2014 Apr; 29(5):663-72. PubMed ID: 24757114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
